BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.71B |
| 2 |
Alibaba
BABA
|
+$2.19B |
| 3 |
Truist Financial
TFC
|
+$2.16B |
| 4 |
iShares MBS ETF
MBB
|
+$841M |
| 5 |
ServiceNow
NOW
|
+$829M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$5.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$2.34B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$983M |
| 4 |
VIAB
Viacom Inc. Class B
VIAB
|
+$684M |
| 5 |
Apple
AAPL
|
+$623M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Financials | 14.42% |
| 3 | Healthcare | 13.59% |
| 4 | Consumer Discretionary | 9.97% |
| 5 | Industrials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BXRX
3576
DELISTED
Baudax Bio, Inc. Common Stock
BXRX
| $3.56M | ﹤0.01% |
+368
| New | +$3.14M |
|
3577
Oaktree Specialty Lending
OCSL
$1.14B
| $3.55M | ﹤0.01% |
216,708
+6,930
| +3% | +$109K |
|
3578
Universal Technical Institute
UTI
$1.59B
| $3.55M | ﹤0.01% |
459,956
-43,968
| -9% | -$265K |
|
|
MJCO
3579
DELISTED
Majesco
MJCO
| $3.54M | ﹤0.01% |
428,924
-185
| -0% | -$1.56K |
|
3580
NextDecade
NEXT
$1.78B
| $3.53M | ﹤0.01% |
574,925
+6,704
| +1% | +$41.7K |
|
3581
Liquidia Corp
LQDA
$8.02B
| $3.53M | ﹤0.01% |
824,989
+1,144
| +0.1% | +$4.59K |
|
3582
Fulcrum Therapeutics
FULC
$297M
| $3.5M | ﹤0.01% |
210,376
+115,776
| +122% | +$1.11M |
|
3583
Siebert Financial
SIEB
$68.4M
| $3.49M | ﹤0.01% |
403,454
+1,058
| +0.3% | +$10.1K |
|
3584
JPMorgan Diversified Return International Equity ETF
JPIN
$377M
| $3.49M | ﹤0.01% |
61,081
+10,064
| +20% | +$556K |
|
3585
Vir Biotechnology
VIR
$1.49B
| $3.48M | ﹤0.01% |
+277,049
| New | +$3.71M |
|
3586
Celcuity
CELC
$4.52B
| $3.46M | ﹤0.01% |
325,343
+310
| +0.1% | +$4.06K |
|
3587
Hallador Energy
HNRG
$696M
| $3.45M | ﹤0.01% |
1,160,120
-7,895
| -0.7% | -$24.2K |
|
3588
Vince Holding Corp
VNCE
$86.8M
| $3.43M | ﹤0.01% |
198,093
+19,499
| +11% | +$408K |
|
3589
Tempest Therapeutics
TPST
$14.6M
| $3.43M | ﹤0.01% |
2,607
+125
| +5% | +$176K |
|
|
TEUM
3590
DELISTED
Pareteum Corporation
TEUM
| $3.42M | ﹤0.01% |
7,814,903
+1,053,575
| +16% | +$608K |
|
3591
Workhorse Group
WKHS
$36.3M
| $3.42M | ﹤0.01% |
375
+13
| +4% | +$120K |
|
3592
Eldorado Gold
EGO
$9.89B
| $3.41M | ﹤0.01% |
424,636
+375,670
| +767% | +$2.91M |
|
3593
Compugen
CGEN
$228M
| $3.4M | ﹤0.01% |
+571,069
| New | +$2.94M |
|
3594
Harvard Bioscience
HBIO
$29.2M
| $3.38M | ﹤0.01% |
110,868
-5,489
| -5% | -$158K |
|
3595
Energous
WATT
$102M
| $3.37M | ﹤0.01% |
3,177
+291
| +10% | +$432K |
|
|
ICAD
3596
DELISTED
iCAD Inc
ICAD
| $3.37M | ﹤0.01% |
433,763
+247
| +0.1% | +$1.76K |
|
3597
inTEST
INTT
$177M
| $3.33M | ﹤0.01% |
558,997
-9,672
| -2% | -$50.9K |
|
3598
Cabaletta Bio
CABA
$455M
| $3.32M | ﹤0.01% |
+237,538
| New | +$2.81M |
|
|
JMEI
3599
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $3.31M | ﹤0.01% |
161,435
-23,933
| -13% | -$474K |
|
3600
KB Financial Group
KB
$43.5B
| $3.3M | ﹤0.01% |
79,645
-22,425
| -22% | -$858K |
|
Similar funds
BlackRock's Q4 2019 Portfolio in Review
As of Q4 2019, BlackRock held 5,193 positions worth $2.61T, up 9.5% from $2.38T the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock's Q4 2019 filing shows 167 new, 2,887 increased, 1,450 reduced and 161 closed positions. Its largest new stake was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M. The largest sale was Celgene Corp, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
- BlackRock's largest Q4 2019 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 324,030 shares worth $382M.
- BlackRock added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.71B increase.
- BlackRock's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $983M.
- BlackRock fully exited Celgene Corp in Q4 2019, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 15% of its $2.61T portfolio in Q4 2019.
- BlackRock opened 167 new positions and closed 161 in Q4 2019.
- BlackRock's portfolio value rose 9.5% quarter-over-quarter to $2.61T.
Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.